Evidensa Utveckling AB
PrivateLast Round
M&A
Apr 2, 2025
Total Funding Raised
$50,000
Company Overview
Evidensa Utveckling AB operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a Seed round in September 2022.
Evidensa Utveckling AB is a digital health company that provides a mobile application offering evidence-based pregnancy tracking, statistical insights, and personalized health information developed by midwives and obstetricians.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Subscription Commerce, Home & Lifestyle
Business Model
B2C
Customer Profile
Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evidensa Utveckling AB Comparables
Compare Evidensa Utveckling AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Preglife | 86% | |
| Preggers | 85% | |
| amma | 80% |
For institutional investors. Book with your work email.
Evidensa Utveckling AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Apr 2, 2025 | ||||
| Seed | Sep 1, 2022 | ||||
| Accelerator | Mar 1, 2021 |
For institutional investors. Book with your work email.
Evidensa Utveckling AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stockholm Innovation & Growth | Accelerator |
| Propel Capital | Accelerator |
| Antler | Seed |
| Amity Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2022
Seed round with participation from Amity Ventures.
- Mar 1, 2021
$50K round from Propel Capital and Stockholm Innovation & Growth.
For institutional investors. Book with your work email.
Evidensa Utveckling AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evidensa Utveckling AB's valuation, stock price, and market status.
Is Evidensa Utveckling AB a public or private company?
Evidensa Utveckling AB is a private company.
What is the current stock price of Evidensa Utveckling AB?
Evidensa Utveckling AB is a private company, so its shares have no public market price. Caplight tracks Evidensa Utveckling AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evidensa Utveckling AB worth (valuation)?
Valuation information for Evidensa Utveckling AB is not publicly available.
Can I buy Evidensa Utveckling AB stock?
Evidensa Utveckling AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evidensa Utveckling AB's last funding round?
Evidensa Utveckling AB's most recent funding round was M&A on April 2, 2025.
Who are the main investors in Evidensa Utveckling AB?
Key investors in Evidensa Utveckling AB include Stockholm Innovation & Growth, Propel Capital, Antler, Amity Ventures.
Will Evidensa Utveckling AB IPO soon?
No public IPO plans have been announced for Evidensa Utveckling AB.
How can I track Evidensa Utveckling AB secondary market activity?
Caplight tracks bids, offers, and trades in Evidensa Utveckling AB's shares on secondary markets.